People · Operator
Named in public records as an officer, director or promoter · active 2018–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Emergent BioSolutions Inc. | — | Biotechnology | Series C | $47.9M | $2.0B | 2018 |
Kathryn C Zoon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kathryn C Zoon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jerome M Hauer | 1 | 2 |
| Ronald B. Richard | 1 | 2 |
| Louis W. Sullivan | 1 | 2 |
| Katherine R Strei | 1 | 1 |
| Fuad El-Hibri | 1 | 1 |
| Adam R Havey | 1 | 1 |
| Sue J Bailey | 1 | 1 |
| Daniel J Abdun-Nabi | 1 | 1 |
| Zsolt J. Harsanyi | 1 | 1 |
| Richard S. Lindahl | 1 | 1 |
| Atul R Saran | 1 | 1 |
| George J. Joulwan | 1 | 1 |
| Robert G Kramer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.